Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
BioMS Medical Corp posted a quarterly profit, helped partly by lower research and development expenses.
For the second quarter, net income was C$1.5 million ($1.35 million), or 2 Canadian cents a share, compared with a loss of C$402,000, or breakeven a share, a year earlier.
Revenue from the company's collaboration agreement rose 6 percent to C$11.9 million.
The biotechnology company's research and development expenses fell 13 percent to C$8.1 million in the second quarter.
Shares of the Edmonton, Alberta-based company were down 1 Canadian cent at C$2.79 Friday after the bell.
(Reporting by Koustav Samanta in Bangalore; Editing by Unnikrishnan Nair)
Petrochemicals group Sasol, the world's leader in making motor fuel from coal, plans to reduce its carbon footprint by capturing its emissions, p...
Online distributor for point of sale equipment, TYSSO and Pegasus.
Partners 
|
© 2009 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
